About

Overview  & History

Founded in 1994, Verdict for Investors was the first independent consultant to predict litigation outcomes on stock prices. Verdict researches a wide variety of legal matters including regulatory changes and mergers to predict how these legal events affect stock prices.

In  addition to Reports & Predictions for institutional investors, Verdict for Investors now offers  Second Opinion: a new service for senior corporate executives, CEOs and Board Members. This service operates on a confidential basis and the information is developed exclusively for individual senior corporate executives, and is never shared with institutional investors. Verdict’s unique experience as a litigation handicapper provides insights which make these Second Opinion solutions useful.

Subscribers to Reports & Predictions of Verdict for Investors have included large mutual fund groups, university endowments, small and large hedge funds and long-short hedge funds.  Seventy percent of our subscribers remained customers for more than 5 years.  Verdict for Investors has remained independent from all institutional affiliations since its inception.  To maintain impartiality, Verdict for Investors never invests in its predictions.

Verdict has published reports on anti-trust, fraud, mass torts, product recalls, mergers, securities and class actions.  Verdict’s Reports and Predictions alert institutional investors to legal events which will impact stock prices, and as equally important to those that will not impact stock prices. Too commonly, lawyers assume all legal issues are critical when, in fact, they are not.  For several years, Verdict specialized in patent infringement cases involving generic drug challenges to pharmaceutical companies on over twelve blockbuster drugs.  During this period, Verdict also prepared a 50-page analysis of asbestos issues and ranked over 400 companies by the degree of their asbestos risk. The ability to conduct both projects simultaneously demonstrates that Verdict is capable of conducting multiple projects by retaining its own lawyers for their particular expertise.

Verdict has reseached the following topics and companies:

Antitrust
BP’ propane
Microsoft
ADM
Great Lakes
UCAR
American Airlines

Fraud
Standard & Poors
Rite Aid
Columbia/HCA

Mass Tort Cases
Asbestos
Benlate (DuPont
Rezulin (Warner Lambert)
Breast Implants (Dow Corning)
Baycol (Bayer)
Lead
Tobacco

Product Recalls
Fen-Phen (AHP/Wyeth)
737 Rudder (Boeing)

Mergers
Whirlpool/Maytag
Pfizer/Warner Lambert/
AHP
HBOC/Republic
WorldCom/Sprint

Securities Class Actions
Avery v. State Farm
Humana
Interpublic Group
McKesson
Merrill Lynch

Biography

Jeff Stewart founded Verdict for Investors in 1994, and continues to write all Research Reports. Stewart graduated from Harvard College and Vanderbilt Law School. A former corporate trial lawyer in Kentucky, he served as in-house counsel at three Fortune 500 companies where he supervised litigation involving antitrust, class actions, fraud, patents, and product recalls.

Disclaimer

The information is intended to provide accurate and authoritative analysis, but Verdict’s publications are published solely on public information without the benefit of direct contacts with management or its representatives. Unforeseen events, inaccurately reported events, inadequate factual information and reversals common to all legal matters should inhibit investor reliance on Verdicts’ publications. None of this information is intended for used by anyone who is not defined as sophisticated investor by the Securities and Exchange Commission. No investor should rely solely on information provided by Verdict in making an investment decisions. Reproduction is forbidden without the publisher’s permission.
 
©2011 Verdict for Investors, Inc